222 related articles for article (PubMed ID: 28475173)
1. MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.
Shen H; Xing C; Cui K; Li Y; Zhang J; Du R; Zhang X; Li Y
Cell Death Differ; 2017 Jul; 24(7):1253-1262. PubMed ID: 28475173
[TBL] [Abstract][Full Text] [Related]
2. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X
Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995
[No Abstract] [Full Text] [Related]
3. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.
Zhang Q; Tang Q; Qin D; Yu L; Huang R; Lv G; Zou Z; Jiang XC; Zou C; Liu W; Luo J; Zhao Z; Muhammad S; Wang G; Chen YG; Wang X
Mol Cell Biol; 2015 Mar; 35(6):988-1000. PubMed ID: 25582198
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
6. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
7. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
[TBL] [Abstract][Full Text] [Related]
8. Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
Weng WH; Leung WH; Pang YJ; Hsu HH
Oncol Rep; 2016 Jan; 35(1):107-16. PubMed ID: 26496897
[TBL] [Abstract][Full Text] [Related]
9. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
10. Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.
Roh MS; Lee HW; Jung SB; Kim K; Lee EH; Park MI; Lee JS; Kim MS
Pathol Res Pract; 2018 Mar; 214(3):350-355. PubMed ID: 29496312
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
12. STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells.
Cheng CC; Yang BL; Chen WC; Ho AS; Sie ZL; Lin HC; Chang CC
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023006
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells.
Hara T; Jones MF; Subramanian M; Li XL; Ou O; Zhu Y; Yang Y; Wakefield LM; Hussain SP; Gaedcke J; Ried T; Luo J; Caplen NJ; Lal A
Oncotarget; 2014 Sep; 5(17):7635-50. PubMed ID: 25245095
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
Chen M; Lin M; Wang X
Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor.
Liu YC; Park YR; Kim SL; Lee ST; Kim SW
Dig Dis Sci; 2017 Nov; 62(11):3040-3049. PubMed ID: 28932920
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.
Park YR; Kim SL; Lee MR; Seo SY; Lee JH; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1915-1927. PubMed ID: 28528497
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.
Xie M; Qin H; Luo Q; Huang Q; He X; Yang Z; Lan P; Lian L
BMC Cancer; 2017 May; 17(1):305. PubMed ID: 28464916
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of microRNA-497-5p inhibits colorectal cancer cell proliferation and invasion via targeting PTPN3.
Hong S; Yan Z; Wang H; Ding L; Bi M
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31350343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
